{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:41:06Z","timestamp":1789814466450,"version":"4.0.1"},"reference-count":180,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>3D bioprinting has emerged as a promising preclinical technology to explore tumor cell biology, interaction with the microenvironment, and drug sensitivity. Current methods allow inclusion of several cell types within the bioprinted objects and may also be compatible with migration of immune cells within the object. 3D bioprinted tumor models have been shown to be more relevant for preclinical studies than classical 2D systems for a number of key parameters including cell morphology, cell-cell interactions, interaction with non-tumor cells, drug diffusion and sensitivity. As compared to other 3D models, bioprinting is applicable to a large variety of tumor cell lines at a relatively low cost and may be performed over a flexible period of time, ranging from a few days to several weeks. Bioprinting has also increasingly been applied to primary samples from cancer patients. In this review, we present the promises and technical hurdles yet to overcome in order for 3D bioprinting models to be fully exploited in preclinical modeling of cancer.<\/jats:p>","DOI":"10.1186\/s40364-026-00951-x","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:47:28Z","timestamp":1781920048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["3D bioprinting for cancer modeling and drug screening"],"prefix":"10.1186","volume":"14","author":[{"given":"Aur\u00e9lie","family":"Cadiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Laure","family":"Peiller Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Petter","family":"Jordheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Duruisseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Marquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Dumontet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"951_CR1","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s40273-021-01065-y","volume":"39","author":"M Schlander","year":"2021","unstructured":"Schlander M, Hernandez-Villafuerte K, Cheng C-Y, Mestre-Ferrandiz J, Baumann M. How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment. PharmacoEconomics. 2021;39:1243\u201369. https:\/\/doi.org\/10.1007\/s40273-021-01065-y.","journal-title":"PharmacoEconomics"},{"key":"951_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd3078","volume":"9","author":"SM Paul","year":"2010","unstructured":"Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, et al. How to improve R&D productivity: the pharmaceutical industry\u2019s grand challenge. Nat Rev Drug Discov. 2010;9:203\u201314. https:\/\/doi.org\/10.1038\/nrd3078.","journal-title":"Nat Rev Drug Discov"},{"key":"951_CR3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/1535370219839163","volume":"244","author":"AB Kunnumakkara","year":"2019","unstructured":"Kunnumakkara AB, Bordoloi D, Sailo BL, Roy NK, Thakur KK, Banik K, et al. Cancer drug development: The missing links. Exp Biol Med Maywood NJ. 2019;244:663\u201389. https:\/\/doi.org\/10.1177\/1535370219839163.","journal-title":"Exp Biol Med Maywood NJ"},{"key":"951_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrd4090","volume":"12","author":"J Arrowsmith","year":"2013","unstructured":"Arrowsmith J, Miller P. Trial watch: phase II and phase III attrition rates 2011\u20132012. Nat Rev Drug Discov. 2013;12:569. https:\/\/doi.org\/10.1038\/nrd4090.","journal-title":"Nat Rev Drug Discov"},{"key":"951_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/d41573-019-00074-z","volume":"18","author":"H Dowden","year":"2019","unstructured":"Dowden H, Munro J. Trends in clinical success rates and therapeutic focus. Nat Rev Drug Discov. 2019;18:495\u20136. https:\/\/doi.org\/10.1038\/d41573-019-00074-z.","journal-title":"Nat Rev Drug Discov"},{"key":"951_CR6","doi-asserted-by":"publisher","first-page":"2002030","DOI":"10.1002\/advs.202002030","volume":"7","author":"DE Ingber","year":"2020","unstructured":"Ingber DE. Is it Time for Reviewer 3 to Request Human Organ Chip Experiments Instead of Animal Validation Studies? Adv Sci Weinh Baden-Wurtt Ger. 2020;7:2002030. https:\/\/doi.org\/10.1002\/advs.202002030.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"951_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/cts.12577","volume":"11","author":"T Takebe","year":"2018","unstructured":"Takebe T, Imai R, Ono S. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development. Clin Transl Sci. 2018;11:597\u2013606. https:\/\/doi.org\/10.1111\/cts.12577.","journal-title":"Clin Transl Sci"},{"key":"951_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","volume":"20","author":"CH Wong","year":"2019","unstructured":"Wong CH, Siah KW, Lo AW. Estimation of clinical trial success rates and related parameters. Biostat Oxf Engl. 2019;20:273\u201386. https:\/\/doi.org\/10.1093\/biostatistics\/kxx069.","journal-title":"Biostat Oxf Engl"},{"key":"951_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrclinonc.2011.34","volume":"8","author":"L Hutchinson","year":"2011","unstructured":"Hutchinson L, Kirk R. High drug attrition rates\u2013where are we going wrong? Nat Rev Clin Oncol. 2011;8:189\u201390. https:\/\/doi.org\/10.1038\/nrclinonc.2011.34.","journal-title":"Nat Rev Clin Oncol"},{"key":"951_CR10","doi-asserted-by":"publisher","first-page":"14821","DOI":"10.1073\/pnas.95.25.14821","volume":"95","author":"F Wang","year":"1998","unstructured":"Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, et al. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci U S A. 1998;95:14821\u20136. https:\/\/doi.org\/10.1073\/pnas.95.25.14821.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"951_CR11","doi-asserted-by":"publisher","first-page":"045005","DOI":"10.1088\/1758-5090\/8\/4\/045005","volume":"8","author":"X Dai","year":"2016","unstructured":"Dai X, Ma C, Lan Q, Xu T. 3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility. Biofabrication. 2016;8:045005. https:\/\/doi.org\/10.1088\/1758-5090\/8\/4\/045005.","journal-title":"Biofabrication"},{"key":"951_CR12","doi-asserted-by":"publisher","unstructured":"Jensen C, Teng Y. Is it time to start transitioning from 2D to 3D cell culture? front mol biosci [Internet]. Frontiers; 2020 [cited 2026 Apr 10];7. https:\/\/doi.org\/10.3389\/fmolb.2020.00033","DOI":"10.3389\/fmolb.2020.00033"},{"key":"951_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10616-025-00714-w","volume":"77","author":"S Bhuker","year":"2025","unstructured":"Bhuker S, Sinha AK, Arora A, Tuli HS, Datta S, Saini AK, et al. Genes and proteins expression profile of 2D vs 3D cancer models: a comparative analysis for better tumor insights. Cytotechnology. 2025;77:51. https:\/\/doi.org\/10.1007\/s10616-025-00714-w.","journal-title":"Cytotechnology"},{"key":"951_CR14","doi-asserted-by":"publisher","first-page":"7444","DOI":"10.3390\/ijms23137444","volume":"23","author":"T Dank\u00f3","year":"2022","unstructured":"Dank\u00f3 T, Pet\u0151v\u00e1ri G, Raffay R, Sztankovics D, Moldvai D, Vetl\u00e9nyi E, et al. Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting. Int J Mol Sci. 2022;23:7444. https:\/\/doi.org\/10.3390\/ijms23137444.","journal-title":"Int J Mol Sci"},{"key":"951_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12935-019-0733-1","volume":"19","author":"S Melissaridou","year":"2019","unstructured":"Melissaridou S, Wiechec E, Magan M, Jain MV, Chung MK, Farnebo L, et al. The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer. Cancer Cell Int. 2019;19:16. https:\/\/doi.org\/10.1186\/s12935-019-0733-1.","journal-title":"Cancer Cell Int"},{"key":"951_CR16","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.2147\/CMAR.S302565","volume":"13","author":"Z Li","year":"2021","unstructured":"Li Z, Zheng W, Wang H, Cheng Y, Fang Y, Wu F, et al. Application of Animal Models in Cancer Research: Recent Progress and Future Prospects. Cancer Manag Res. 2021;13:2455\u201375. https:\/\/doi.org\/10.2147\/CMAR.S302565.","journal-title":"Cancer Manag Res"},{"key":"951_CR17","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.1038\/s41598-019-42680-2","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu Y, Chanana P, Davila JI, Hou X, Zanfagnin V, McGehee CD, et al. Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts. Sci Rep. 2019;9:6314. https:\/\/doi.org\/10.1038\/s41598-019-42680-2.","journal-title":"Sci Rep"},{"key":"951_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther. 2023;8:160. https:\/\/doi.org\/10.1038\/s41392-023-01419-2.","journal-title":"Signal Transduct Target Ther"},{"key":"951_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12967-022-03405-8","volume":"20","author":"S Abdolahi","year":"2022","unstructured":"Abdolahi S, Ghazvinian Z, Muhammadnejad S, Saleh M, Asadzadeh Aghdaei H, Baghaei K. Patient-derived xenograft (PDX) models, applications and challenges in cancer research. J Transl Med. 2022;20:206. https:\/\/doi.org\/10.1186\/s12967-022-03405-8.","journal-title":"J Transl Med"},{"key":"951_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1152\/physiol.00036.2016","volume":"32","author":"K Duval","year":"2017","unstructured":"Duval K, Grover H, Han L-H, Mou Y, Pegoraro AF, Fredberg J, et al. Modeling Physiological Events in 2D vs. 3D Cell Culture. Physiology. 2017;32:266\u201377. https:\/\/doi.org\/10.1152\/physiol.00036.2016.","journal-title":"Physiology"},{"key":"951_CR21","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1242\/jcs.079509","volume":"125","author":"BM Baker","year":"2012","unstructured":"Baker BM, Chen CS. Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci. 2012;125:3015\u201324. https:\/\/doi.org\/10.1242\/jcs.079509.","journal-title":"J Cell Sci"},{"key":"951_CR22","doi-asserted-by":"publisher","first-page":"12200","DOI":"10.3390\/ijms222212200","volume":"22","author":"O Habanjar","year":"2021","unstructured":"Habanjar O, Diab-Assaf M, Caldefie-Chezet F, Delort L. 3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages. Int J Mol Sci. 2021;22:12200. https:\/\/doi.org\/10.3390\/ijms222212200.","journal-title":"Int J Mol Sci"},{"key":"951_CR23","doi-asserted-by":"publisher","DOI":"10.3791\/59714","author":"MG Rolver","year":"2019","unstructured":"Rolver MG, Elingaard-Larsen LO, Pedersen SF. Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells. J Vis Exp JoVE. 2019. https:\/\/doi.org\/10.3791\/59714.","journal-title":"J Vis Exp JoVE"},{"key":"951_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","volume":"18","author":"J Drost","year":"2018","unstructured":"Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018;18:407\u201318. https:\/\/doi.org\/10.1038\/s41568-018-0007-6.","journal-title":"Nat Rev Cancer"},{"key":"951_CR25","doi-asserted-by":"publisher","first-page":"110264","DOI":"10.1016\/j.msec.2019.110264","volume":"107","author":"JC Fontoura","year":"2020","unstructured":"Fontoura JC, Viezzer C, Dos Santos FG, Ligabue RA, Weinlich R, Puga RD, et al. Comparison of 2D and 3D cell culture models for cell growth, gene expression and drug resistance. Mater Sci Eng C Mater Biol Appl. 2020;107:110264. https:\/\/doi.org\/10.1016\/j.msec.2019.110264.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"951_CR26","doi-asserted-by":"publisher","first-page":"e70136","DOI":"10.1002\/pmic.70136","volume":"26","author":"Y Shiota","year":"2026","unstructured":"Shiota Y, Fujita I, Hayashi S, Ohtsuki S, Kondo T. Integrated Transcriptomic, Proteomic, and Pharmacologic Profiling of 2D and 3D Patient-Derived GCTB Cell Lines Reveals Culture-Dependent Drug Response Determinants. Proteomics. 2026;26:e70136. https:\/\/doi.org\/10.1002\/pmic.70136.","journal-title":"Proteomics"},{"key":"951_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","volume":"17","author":"L-B Weiswald","year":"2015","unstructured":"Weiswald L-B, Bellet D, Dangles-Marie V. Spherical cancer models in tumor biology. Neoplasia N Y N. 2015;17:1\u201315. https:\/\/doi.org\/10.1016\/j.neo.2014.12.004.","journal-title":"Neoplasia N Y N"},{"key":"951_CR28","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.biotechadv.2016.11.002","volume":"34","author":"EC Costa","year":"2016","unstructured":"Costa EC, Moreira AF, de Melo-Diogo D, Gaspar VM, Carvalho MP, Correia IJ. 3D tumor spheroids: an overview on the tools and techniques used for their analysis. Biotechnol Adv. 2016;34:1427\u201341. https:\/\/doi.org\/10.1016\/j.biotechadv.2016.11.002.","journal-title":"Biotechnol Adv"},{"key":"951_CR29","doi-asserted-by":"publisher","first-page":"123184","DOI":"10.1016\/j.lfs.2024.123184","volume":"358","author":"T Patel","year":"2024","unstructured":"Patel T, Jain N. Multicellular tumor spheroids: A convenient in vitro model for translational cancer research. Life Sci. 2024;358:123184. https:\/\/doi.org\/10.1016\/j.lfs.2024.123184.","journal-title":"Life Sci"},{"key":"951_CR30","doi-asserted-by":"publisher","first-page":"100620","DOI":"10.1016\/j.xinn.2024.100620","volume":"5","author":"X Han","year":"2024","unstructured":"Han X, Cai C, Deng W, Shi Y, Li L, Wang C, et al. Landscape of human organoids: Ideal model in clinics and research. Innov. 2024;5:100620. https:\/\/doi.org\/10.1016\/j.xinn.2024.100620.","journal-title":"Innov"},{"key":"951_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/13880209.2025.2458149","volume":"63","author":"R Cong","year":"2025","unstructured":"Cong R, Lu C, Li X, Xu Z, Wang Y, Sun S. Tumor organoids in cancer medicine: from model systems to natural compound screening. Pharm Biol Taylor Francis. 2025;63:89\u2013109. https:\/\/doi.org\/10.1080\/13880209.2025.2458149.","journal-title":"Pharm Biol Taylor Francis"},{"key":"951_CR32","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.3390\/ijms23073432","volume":"23","author":"N Germain","year":"2022","unstructured":"Germain N, Dhayer M, Dekiouk S, Marchetti P. Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine. Int J Mol Sci Multidisciplinary Digit Publishing Inst. 2022;23:3432. https:\/\/doi.org\/10.3390\/ijms23073432.","journal-title":"Int J Mol Sci Multidisciplinary Digit Publishing Inst"},{"key":"951_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41578-020-0199-8","volume":"5","author":"EA Aisenbrey","year":"2020","unstructured":"Aisenbrey EA, Murphy WL. Synthetic alternatives to Matrigel. Nat Rev Mater. 2020;5:539\u201351. https:\/\/doi.org\/10.1038\/s41578-020-0199-8.","journal-title":"Nat Rev Mater"},{"key":"951_CR34","doi-asserted-by":"publisher","first-page":"013001","DOI":"10.1088\/1758-5090\/aaec52","volume":"11","author":"J Groll","year":"2018","unstructured":"Groll J, Burdick JA, Cho D-W, Derby B, Gelinsky M, Heilshorn SC, et al. A definition of bioinks and their distinction from biomaterial inks. Biofabrication. 2018;11:013001. https:\/\/doi.org\/10.1088\/1758-5090\/aaec52.","journal-title":"Biofabrication"},{"key":"951_CR35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1109\/TBME.2013.2243912","volume":"60","author":"IT Ozbolat","year":"2013","unstructured":"Ozbolat IT, Yu Y. Bioprinting toward organ fabrication: challenges and future trends. IEEE Trans Biomed Eng. 2013;60:691\u20139. https:\/\/doi.org\/10.1109\/TBME.2013.2243912.","journal-title":"IEEE Trans Biomed Eng"},{"key":"951_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0520-2","volume-title":"3D Bioprinting: Principles and Protocols [Internet]","year":"2020","unstructured":"Crook JM, editor. 3D Bioprinting: Principles and Protocols [Internet]. New York, NY: Springer US; 2020. [cited 2026 Feb 10]. https:\/\/doi.org\/10.1007\/978-1-0716-0520-2."},{"key":"951_CR37","doi-asserted-by":"publisher","first-page":"103163","DOI":"10.1016\/j.cis.2024.103163","volume":"328","author":"U Shashikumar","year":"2024","unstructured":"Shashikumar U, Saraswat A, Deshmukh K, Hussain CM, Chandra P, Tsai P-C, et al. Innovative technologies for the fabrication of 3D\/4D smart hydrogels and its biomedical applications - A comprehensive review. Adv Colloid Interface Sci. 2024;328:103163. https:\/\/doi.org\/10.1016\/j.cis.2024.103163.","journal-title":"Adv Colloid Interface Sci"},{"key":"951_CR38","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.tibtech.2017.10.015","volume":"36","author":"L Moroni","year":"2018","unstructured":"Moroni L, Boland T, Burdick JA, Maria CD, Derby B, Forgacs G, et al. Biofabrication: A Guide to Technology and Terminology. Trends Biotechnol Elsevier. 2018;36:384\u2013402. https:\/\/doi.org\/10.1016\/j.tibtech.2017.10.015.","journal-title":"Trends Biotechnol Elsevier"},{"key":"951_CR39","doi-asserted-by":"publisher","first-page":"022002","DOI":"10.1088\/1758-5090\/ab5158","volume":"12","author":"W Sun","year":"2020","unstructured":"Sun W, Starly B, Daly AC, Burdick JA, Groll J, Skeldon G, et al. The bioprinting roadmap. Biofabrication IOP Publishing. 2020;12:022002. https:\/\/doi.org\/10.1088\/1758-5090\/ab5158.","journal-title":"Biofabrication IOP Publishing"},{"key":"951_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cell.2020.12.002","volume":"184","author":"AC Daly","year":"2021","unstructured":"Daly AC, Prendergast ME, Hughes AJ, Burdick JA. Bioprinting for the Biologist. Cell Elsevier. 2021;184:18\u201332. https:\/\/doi.org\/10.1016\/j.cell.2020.12.002.","journal-title":"Cell Elsevier"},{"key":"951_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1089\/ten.tea.2019.0298","volume":"26","author":"KA Deo","year":"2020","unstructured":"Deo KA, Singh KA, Peak CW, Alge DL, Gaharwar AK. Bioprinting 101: Design, Fabrication, and Evaluation of Cell-Laden 3D Bioprinted Scaffolds. Tissue Eng Part A. 2020;26:318\u201338. https:\/\/doi.org\/10.1089\/ten.tea.2019.0298.","journal-title":"Tissue Eng Part A"},{"key":"951_CR42","doi-asserted-by":"publisher","unstructured":"Horder H, B\u00f6hringer D, Endrizzi N, Hildebrand LS, Cianciosi A, Stecher S, et al. Cancer cell migration depends on adjacent ASC and adipose spheroids in a 3D bioprinted breast cancer model. Biofabrication. 2024;16. https:\/\/doi.org\/10.1088\/1758-5090\/ad57f7.","DOI":"10.1088\/1758-5090\/ad57f7"},{"key":"951_CR43","doi-asserted-by":"publisher","first-page":"2203966","DOI":"10.1002\/adfm.202203966","volume":"32","author":"M Dey","year":"2022","unstructured":"Dey M, Kim MH, Dogan M, Nagamine M, Kozhaya L, Celik N, et al. Chemotherapeutics and CAR-T Cell-Based Immunotherapeutics Screening on a 3D Bioprinted Vascularized Breast Tumor Model. Adv Funct Mater. 2022;32:2203966. https:\/\/doi.org\/10.1002\/adfm.202203966.","journal-title":"Adv Funct Mater"},{"key":"951_CR44","doi-asserted-by":"publisher","first-page":"025003","DOI":"10.1088\/1758-5090\/aafc49","volume":"11","author":"S Swaminathan","year":"2019","unstructured":"Swaminathan S, Hamid Q, Sun W, Clyne AM. Bioprinting of 3D breast epithelial spheroids for human cancer models. Biofabrication. 2019;11:025003. https:\/\/doi.org\/10.1088\/1758-5090\/aafc49.","journal-title":"Biofabrication"},{"key":"951_CR45","doi-asserted-by":"publisher","unstructured":"Dey M, Kim MH, Nagamine M, Karhan E, Kozhaya L, Dogan M, et al. Biofabrication of 3D breast cancer models for dissecting the cytotoxic response of human T cells expressing engineered MAIT cell receptors. Biofabrication. 2022;14. https:\/\/doi.org\/10.1088\/1758-5090\/ac925a.","DOI":"10.1088\/1758-5090\/ac925a"},{"key":"951_CR46","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.actbio.2021.10.031","volume":"138","author":"S Hong","year":"2022","unstructured":"Hong S, Song JM. 3D bioprinted drug-resistant breast cancer spheroids for quantitative in situ evaluation of drug resistance. Acta Biomater. 2022;138:228\u201339. https:\/\/doi.org\/10.1016\/j.actbio.2021.10.031.","journal-title":"Acta Biomater"},{"key":"951_CR47","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/cells10040803","volume":"10","author":"H Horder","year":"2021","unstructured":"Horder H, Guaza Lasheras M, Grummel N, Nadernezhad A, Herbig J, Erg\u00fcn S, et al. Bioprinting and Differentiation of Adipose-Derived Stromal Cell Spheroids for a 3D Breast Cancer-Adipose Tissue Model. Cells Multidisciplinary Digit Publishing Inst. 2021;10:803. https:\/\/doi.org\/10.3390\/cells10040803.","journal-title":"Cells Multidisciplinary Digit Publishing Inst"},{"key":"951_CR48","doi-asserted-by":"publisher","first-page":"e00231","DOI":"10.1016\/j.bprint.2022.e00231","volume":"28","author":"CD Morley","year":"2022","unstructured":"Morley CD, Flores CT, Drake JA, Moore GL, Mitchell DA, Angelini TE. Spatiotemporal T cell dynamics in a 3D bioprinted immunotherapy model. Bioprinting. 2022;28:e00231. https:\/\/doi.org\/10.1016\/j.bprint.2022.e00231.","journal-title":"Bioprinting"},{"key":"951_CR49","doi-asserted-by":"publisher","first-page":"e2200244","DOI":"10.1002\/advs.202200244","volume":"9","author":"L Ning","year":"2022","unstructured":"Ning L, Shim J, Tomov ML, Liu R, Mehta R, Mingee A, et al. A 3D Bioprinted in vitro Model of Neuroblastoma Recapitulates Dynamic Tumor-Endothelial Cell Interactions Contributing to Solid Tumor Aggressive Behavior. Adv Sci Weinh Baden-Wurtt Ger. 2022;9:e2200244. https:\/\/doi.org\/10.1002\/advs.202200244.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"951_CR50","doi-asserted-by":"publisher","first-page":"2306676","DOI":"10.1002\/adfm.202306676","volume":"34","author":"J Kim","year":"2024","unstructured":"Kim J, Kim J, Gao G, Choi Y, Kim J, Cho D-W, et al. Bioprinted Organoids Platform with Tumor Vasculature for Implementing Precision Personalized Medicine Targeted Towards Gastric Cancer. Adv Funct Mater. 2024;34:2306676. https:\/\/doi.org\/10.1002\/adfm.202306676.","journal-title":"Adv Funct Mater"},{"key":"951_CR51","doi-asserted-by":"publisher","first-page":"444","DOI":"10.18063\/ijb.v7i4.444","volume":"7","author":"P Zhuang","year":"2021","unstructured":"Zhuang P, Chiang Y-H, Fernanda MS, He M. Using Spheroids as Building Blocks Towards 3D Bioprinting of Tumor Microenvironment. Int J Bioprinting. 2021;7:444. https:\/\/doi.org\/10.18063\/ijb.v7i4.444.","journal-title":"Int J Bioprinting"},{"key":"951_CR52","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.biotechadv.2016.12.006","volume":"35","author":"M Hospodiuk","year":"2017","unstructured":"Hospodiuk M, Dey M, Sosnoski D, Ozbolat IT. The bioink: A comprehensive review on bioprintable materials. Biotechnol Adv. 2017;35:217\u201339. https:\/\/doi.org\/10.1016\/j.biotechadv.2016.12.006.","journal-title":"Biotechnol Adv"},{"key":"951_CR53","doi-asserted-by":"publisher","first-page":"e1901648","DOI":"10.1002\/adhm.201901648","volume":"9","author":"X Cui","year":"2020","unstructured":"Cui X, Li J, Hartanto Y, Durham M, Tang J, Zhang H, et al. Advances in Extrusion 3D Bioprinting: A Focus on Multicomponent Hydrogel-Based Bioinks. Adv Healthc Mater. 2020;9:e1901648. https:\/\/doi.org\/10.1002\/adhm.201901648.","journal-title":"Adv Healthc Mater"},{"key":"951_CR54","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1021\/cr000108x","volume":"101","author":"KY Lee","year":"2001","unstructured":"Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev. 2001;101:1869\u201379. https:\/\/doi.org\/10.1021\/cr000108x.","journal-title":"Chem Rev"},{"key":"951_CR55","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/bit.22361","volume":"103","author":"MW Tibbitt","year":"2009","unstructured":"Tibbitt MW, Anseth KS. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng. 2009;103:655\u201363. https:\/\/doi.org\/10.1002\/bit.22361.","journal-title":"Biotechnol Bioeng"},{"key":"951_CR56","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1021\/acsbiomaterials.6b00246","volume":"2","author":"YS Zhang","year":"2016","unstructured":"Zhang YS, Duchamp M, Oklu R, Ellisen LW, Langer R, Khademhosseini A. Bioprinting the Cancer Microenvironment. ACS Biomater Sci Eng. 2016;2:1710\u201321. https:\/\/doi.org\/10.1021\/acsbiomaterials.6b00246.","journal-title":"ACS Biomater Sci Eng"},{"key":"951_CR57","doi-asserted-by":"publisher","first-page":"131288","DOI":"10.1016\/j.colsurfa.2023.131288","volume":"666","author":"Q Dong","year":"2023","unstructured":"Dong Q, Su X, Li X, Zhou H, Jian H, Bai S, et al. In vitro construction of lung cancer organoids by 3D bioprinting for drug evaluation. Colloids Surf Physicochem Eng Asp. 2023;666:131288. https:\/\/doi.org\/10.1016\/j.colsurfa.2023.131288.","journal-title":"Colloids Surf Physicochem Eng Asp"},{"key":"951_CR58","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.3390\/ijms21082993","volume":"21","author":"S Han","year":"2020","unstructured":"Han S, Kim S, Chen Z, Shin HK, Lee S-Y, Moon HE, et al. 3D Bioprinted Vascularized Tumour for Drug Testing. Int J Mol Sci. 2020;21:2993. https:\/\/doi.org\/10.3390\/ijms21082993.","journal-title":"Int J Mol Sci"},{"key":"951_CR59","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40824-023-00403-9","volume":"27","author":"D Kim","year":"2023","unstructured":"Kim D, Jo S, Lee D, Kim S-M, Seok JM, Yeo SJ, et al. NK cells encapsulated in micro\/macropore-forming hydrogels via 3D bioprinting for tumor immunotherapy. Biomater Res Am Association Advancement Sci. 2023;27:60. https:\/\/doi.org\/10.1186\/s40824-023-00403-9.","journal-title":"Biomater Res Am Association Advancement Sci"},{"key":"951_CR60","doi-asserted-by":"publisher","unstructured":"Mazzaglia C, Sheng Y, Rodrigues LN, Lei IM, Shields JD, Huang YYS. Deployable extrusion bioprinting of compartmental tumoroids with cancer associated fibroblasts for immune cell interactions. Biofabrication. 2023;15. https:\/\/doi.org\/10.1088\/1758-5090\/acb1db.","DOI":"10.1088\/1758-5090\/acb1db"},{"key":"951_CR61","doi-asserted-by":"publisher","DOI":"10.1039\/d5tb01845e","author":"J Wang","year":"2025","unstructured":"Wang J, Peng Y, Miao T, Li Y, Li Y, He Z, et al. A 3D bioprinted liposarcoma tumor microenvironment model recapitulates stroma-driven invasion and chemoresistance. J Mater Chem B. 2025. https:\/\/doi.org\/10.1039\/d5tb01845e.","journal-title":"J Mater Chem B"},{"key":"951_CR62","doi-asserted-by":"publisher","first-page":"120395","DOI":"10.1016\/j.carbpol.2022.120395","volume":"302","author":"F Cadamuro","year":"2023","unstructured":"Cadamuro F, Marongiu L, Marino M, Tamini N, Nespoli L, Zucchini N, et al. 3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans. Carbohydr Polym. 2023;302:120395. https:\/\/doi.org\/10.1016\/j.carbpol.2022.120395.","journal-title":"Carbohydr Polym"},{"key":"951_CR63","doi-asserted-by":"publisher","first-page":"119744","DOI":"10.1016\/j.biomaterials.2019.119744","volume":"232","author":"V Brancato","year":"2020","unstructured":"Brancato V, Oliveira JM, Correlo VM, Reis RL, Kundu SC. Could 3D models of cancer enhance drug screening? Biomaterials. 2020;232:119744. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119744.","journal-title":"Biomaterials"},{"key":"951_CR64","doi-asserted-by":"publisher","first-page":"7913","DOI":"10.1016\/j.biomaterials.2011.07.005","volume":"32","author":"B Ananthanarayanan","year":"2011","unstructured":"Ananthanarayanan B, Kim Y, Kumar S. Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform. Biomaterials. 2011;32:7913\u201323. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.07.005.","journal-title":"Biomaterials"},{"key":"951_CR65","doi-asserted-by":"publisher","first-page":"030401","DOI":"10.1063\/5.0018548","volume":"4","author":"L Bian","year":"2020","unstructured":"Bian L. Functional hydrogel bioink, a key challenge of 3D cellular bioprinting. APL Bioeng. 2020;4:030401. https:\/\/doi.org\/10.1063\/5.0018548.","journal-title":"APL Bioeng"},{"key":"951_CR66","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1038\/ncomms4935","volume":"5","author":"F Pati","year":"2014","unstructured":"Pati F, Jang J, Ha D-H, Won Kim S, Rhie J-W, Shim J-H, et al. Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink. Nat Commun. 2014;5:3935. https:\/\/doi.org\/10.1038\/ncomms4935.","journal-title":"Nat Commun"},{"key":"951_CR67","doi-asserted-by":"publisher","first-page":"034104","DOI":"10.1088\/1758-5090\/aa7e98","volume":"9","author":"BS Kim","year":"2017","unstructured":"Kim BS, Kim H, Gao G, Jang J, Cho D-W. Decellularized extracellular matrix: a step towards the next generation source for bioink manufacturing. Biofabrication. 2017;9:034104. https:\/\/doi.org\/10.1088\/1758-5090\/aa7e98.","journal-title":"Biofabrication"},{"key":"951_CR68","doi-asserted-by":"publisher","first-page":"100826","DOI":"10.1016\/j.mtbio.2023.100826","volume":"23","author":"P Gonz\u00e1lez-Callejo","year":"2023","unstructured":"Gonz\u00e1lez-Callejo P, V\u00e1zquez-Aristizabal P, Garc\u00eda-Astrain C, Jimenez de Aberasturi D, Henriksen-Lacey M, Izeta A, et al. 3D bioprinted breast tumor-stroma models for pre-clinical drug testing. Mater Today Bio. 2023;23:100826. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100826.","journal-title":"Mater Today Bio"},{"key":"951_CR69","doi-asserted-by":"publisher","first-page":"27151","DOI":"10.1021\/acsami.4c04135","volume":"16","author":"P Gonz\u00e1lez-Callejo","year":"2024","unstructured":"Gonz\u00e1lez-Callejo P, Garc\u00eda-Astrain C, Herrero-Ruiz A, Henriksen-Lacey M, Seras-Franzoso J, Abasolo I, et al. 3D Bioprinted Tumor-Stroma Models of Triple-Negative Breast Cancer Stem Cells for Preclinical Targeted Therapy Evaluation. ACS Appl Mater Interfaces Am Chem Soc. 2024;16:27151\u201363. https:\/\/doi.org\/10.1021\/acsami.4c04135.","journal-title":"ACS Appl Mater Interfaces Am Chem Soc"},{"key":"951_CR70","doi-asserted-by":"publisher","first-page":"025002","DOI":"10.1088\/1758-5090\/ac48e4","volume":"14","author":"Y Chen","year":"2022","unstructured":"Chen Y, Xu L, Li W, Chen W, He Q, Zhang X, et al. 3D bioprinted tumor model with extracellular matrix enhanced bioinks for nanoparticle evaluation. Biofabrication IOP Publishing. 2022;14:025002. https:\/\/doi.org\/10.1088\/1758-5090\/ac48e4.","journal-title":"Biofabrication IOP Publishing"},{"key":"951_CR71","doi-asserted-by":"publisher","first-page":"29467","DOI":"10.1021\/acsami.2c00920","volume":"14","author":"B Blanco-Fernandez","year":"2022","unstructured":"Blanco-Fernandez B, Rey-Vinolas S, Ba\u011fc\u0131 G, Rubi-Sans G, Otero J, Navajas D, et al. Bioprinting Decellularized Breast Tissue for the Development of Three-Dimensional Breast Cancer Models. ACS Appl Mater Interfaces. 2022;14:29467\u201382. https:\/\/doi.org\/10.1021\/acsami.2c00920.","journal-title":"ACS Appl Mater Interfaces"},{"key":"951_CR72","doi-asserted-by":"publisher","first-page":"10167","DOI":"10.1021\/acsami.2c00312","volume":"14","author":"G Janani","year":"2022","unstructured":"Janani G, Priya S, Dey S, Mandal BB. Mimicking Native Liver Lobule Microarchitecture In Vitro with Parenchymal and Non-parenchymal Cells Using 3D Bioprinting for Drug Toxicity and Drug Screening Applications. ACS Appl Mater Interfaces Am Chem Soc. 2022;14:10167\u201386. https:\/\/doi.org\/10.1021\/acsami.2c00312.","journal-title":"ACS Appl Mater Interfaces Am Chem Soc"},{"key":"951_CR73","doi-asserted-by":"publisher","first-page":"630","DOI":"10.18063\/ijb.v9i1.630","volume":"9","author":"J Xu","year":"2023","unstructured":"Xu J, Yang S, Su Y, Hu X, Xi Y, Cheng YY, et al. A 3D bioprinted tumor model fabricated with gelatin\/sodium alginate\/decellularized extracellular matrix bioink. Int J Bioprinting. 2023;9:630. https:\/\/doi.org\/10.18063\/ijb.v9i1.630.","journal-title":"Int J Bioprinting"},{"key":"951_CR74","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.7150\/thno.81785","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wang Y, Zheng Z, Wei X, Chen L, Wu Y, et al. Strategies for improving the 3D printability of decellularized extracellular matrix bioink. Theranostics. 2023;13:2562\u201387. https:\/\/doi.org\/10.7150\/thno.81785.","journal-title":"Theranostics"},{"key":"951_CR75","doi-asserted-by":"publisher","first-page":"045014","DOI":"10.1088\/1758-5090\/aba0c3","volume":"12","author":"S Mao","year":"2020","unstructured":"Mao S, He J, Zhao Y, Liu T, Xie F, Yang H, et al. Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: establishment, evaluation and anti-cancer drug testing. Biofabrication IOP Publishing. 2020;12:045014. https:\/\/doi.org\/10.1088\/1758-5090\/aba0c3.","journal-title":"Biofabrication IOP Publishing"},{"key":"951_CR76","doi-asserted-by":"publisher","first-page":"025001","DOI":"10.1088\/1758-5090\/abdb87","volume":"13","author":"S Flores-Torres","year":"2021","unstructured":"Flores-Torres S, Peza-Chavez O, Kuasne H, Munguia-Lopez JG, Kort-Mascort J, Ferri L, et al. Alginate\u2013gelatin\u2013Matrigel hydrogels enable the development and multigenerational passaging of patient-derived 3D bioprinted cancer spheroid models. Biofabrication. 2021;13:025001. https:\/\/doi.org\/10.1088\/1758-5090\/abdb87.","journal-title":"Biofabrication"},{"key":"951_CR77","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.3390\/polym13122026","volume":"13","author":"P De Stefano","year":"2021","unstructured":"De Stefano P, Briatico-Vangosa F, Bianchi E, Pellegata AF, Hartung de Hartungen A, Corti P, et al. Bioprinting of Matrigel Scaffolds for Cancer Research. Polymers. 2021;13:2026. https:\/\/doi.org\/10.3390\/polym13122026.","journal-title":"Polymers"},{"key":"951_CR78","doi-asserted-by":"publisher","first-page":"034102","DOI":"10.1088\/1758-5090\/ab256c","volume":"11","author":"Y Li","year":"2019","unstructured":"Li Y, Zhang T, Pang Y, Li L, Chen Z-N, Sun W. 3D bioprinting of hepatoma cells and application with microfluidics for pharmacodynamic test of Metuzumab. Biofabrication IOP Publishing. 2019;11:034102. https:\/\/doi.org\/10.1088\/1758-5090\/ab256c.","journal-title":"Biofabrication IOP Publishing"},{"key":"951_CR79","doi-asserted-by":"publisher","first-page":"e2400035","DOI":"10.1002\/mabi.202400035","volume":"24","author":"P Shukla","year":"2024","unstructured":"Shukla P, Bera AK, Yeleswarapu S, Pati F. High Throughput Bioprinting Using Decellularized Adipose Tissue-Based Hydrogels for 3D Breast Cancer Modeling. Macromol Biosci. 2024;24:e2400035. https:\/\/doi.org\/10.1002\/mabi.202400035.","journal-title":"Macromol Biosci"},{"key":"951_CR80","doi-asserted-by":"publisher","first-page":"119536","DOI":"10.1016\/j.biomaterials.2019.119536","volume":"226","author":"I Matai","year":"2020","unstructured":"Matai I, Kaur G, Seyedsalehi A, McClinton A, Laurencin CT. Progress in 3D bioprinting technology for tissue\/organ regenerative engineering. Biomaterials. 2020;226:119536. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119536.","journal-title":"Biomaterials"},{"key":"951_CR81","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-0716-0520-2_6","volume-title":"3D Bioprinting Princ Protoc [Internet]","author":"H Kumar","year":"2020","unstructured":"Kumar H, Kim K. Stereolithography 3D Bioprinting. In: Crook JM, editor. 3D Bioprinting Princ Protoc [Internet]. New York, NY: Springer US; 2020. pp. 93\u2013108. [cited 2025 Nov 16]. https:\/\/doi.org\/10.1007\/978-1-0716-0520-2_6."},{"key":"951_CR82","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.4155\/fmc.10.253","volume":"2","author":"AM Kasko","year":"2010","unstructured":"Kasko AM, Wong DY. Two-photon lithography in the future of cell-based therapeutics and regenerative medicine: a review of techniques for hydrogel patterning and controlled release. Future Med Chem. 2010;2:1669\u201380. https:\/\/doi.org\/10.4155\/fmc.10.253.","journal-title":"Future Med Chem"},{"key":"951_CR83","doi-asserted-by":"publisher","first-page":"10662","DOI":"10.1021\/acs.chemrev.9b00812","volume":"120","author":"KS Lim","year":"2020","unstructured":"Lim KS, Galarraga JH, Cui X, Lindberg GCJ, Burdick JA, Woodfield TBF. Fundamentals and Applications of Photo-Cross-Linking in Bioprinting. Chem Rev. 2020;120:10662\u201394. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00812.","journal-title":"Chem Rev"},{"key":"951_CR84","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.3390\/ma16237461","volume":"16","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang X, Li Y, Zhang Y. Applications of Light-Based 3D Bioprinting and Photoactive Biomaterials for Tissue Engineering. Mater Basel Switz. 2023;16:7461. https:\/\/doi.org\/10.3390\/ma16237461.","journal-title":"Mater Basel Switz"},{"key":"951_CR85","doi-asserted-by":"publisher","first-page":"10793","DOI":"10.1021\/acs.chemrev.0c00008","volume":"120","author":"X Li","year":"2020","unstructured":"Li X, Liu B, Pei B, Chen J, Zhou D, Peng J, et al. Inkjet Bioprinting of Biomaterials. Chem Rev Am Chem Soc. 2020;120:10793\u2013833. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00008.","journal-title":"Chem Rev Am Chem Soc"},{"key":"951_CR86","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1002\/adma.201302042","volume":"25","author":"J Malda","year":"2013","unstructured":"Malda J, Visser J, Melchels FP, J\u00fcngst T, Hennink WE, Dhert WJA, et al. 25th anniversary article: Engineering hydrogels for biofabrication. Adv Mater Deerfield Beach Fla. 2013;25:5011\u201328. https:\/\/doi.org\/10.1002\/adma.201302042.","journal-title":"Adv Mater Deerfield Beach Fla"},{"key":"951_CR87","first-page":"91","volume":"14","author":"L Koch","year":"2013","unstructured":"Koch L, Gruene M, Unger C, Chichkov B. Laser assisted cell printing. Curr Pharm Biotechnol. 2013;14:91\u20137.","journal-title":"Curr Pharm Biotechnol"},{"key":"951_CR88","doi-asserted-by":"publisher","first-page":"1255782","DOI":"10.3389\/fbioe.2023.1255782","volume":"11","author":"J Chang","year":"2023","unstructured":"Chang J, Sun X. Laser-induced forward transfer based laser bioprinting in biomedical applications. Front Bioeng Biotechnol. 2023;11:1255782. https:\/\/doi.org\/10.3389\/fbioe.2023.1255782.","journal-title":"Front Bioeng Biotechnol"},{"key":"951_CR89","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.biomaterials.2015.10.076","volume":"76","author":"IT Ozbolat","year":"2016","unstructured":"Ozbolat IT, Hospodiuk M. Current advances and future perspectives in extrusion-based bioprinting. Biomaterials. 2016;76:321\u201343. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.10.076.","journal-title":"Biomaterials"},{"key":"951_CR90","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41598-017-01581-y","volume":"7","author":"X Dai","year":"2017","unstructured":"Dai X, Liu L, Ouyang J, Li X, Zhang X, Lan Q, et al. Coaxial 3D bioprinting of self-assembled multicellular heterogeneous tumor fibers. Sci Rep. 2017;7:1457. https:\/\/doi.org\/10.1038\/s41598-017-01581-y.","journal-title":"Sci Rep"},{"key":"951_CR91","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nmeth.3839","volume":"13","author":"SR Caliari","year":"2016","unstructured":"Caliari SR, Burdick JA. A practical guide to hydrogels for cell culture. Nat Methods. 2016;13:405\u201314. https:\/\/doi.org\/10.1038\/nmeth.3839.","journal-title":"Nat Methods"},{"key":"951_CR92","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1021\/acsbiomaterials.8b01277","volume":"4","author":"Y Wang","year":"2018","unstructured":"Wang Y, Shi W, Kuss M, Mirza S, Qi D, Krasnoslobodtsev A, et al. 3D Bioprinting of Breast Cancer Models for Drug Resistance Study. ACS Biomater Sci Eng. 2018;4:4401\u201311. https:\/\/doi.org\/10.1021\/acsbiomaterials.8b01277.","journal-title":"ACS Biomater Sci Eng"},{"key":"951_CR93","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1021\/acsabm.0c00169","volume":"3","author":"H Rastin","year":"2020","unstructured":"Rastin H, Ormsby RT, Atkins GJ, Losic D. 3D Bioprinting of Methylcellulose\/Gelatin-Methacryloyl (MC\/GelMA) Bioink with High Shape Integrity. ACS Appl Bio Mater. 2020;3:1815\u201326. https:\/\/doi.org\/10.1021\/acsabm.0c00169.","journal-title":"ACS Appl Bio Mater"},{"key":"951_CR94","doi-asserted-by":"publisher","unstructured":"Domingues MF, Carreira MC, Santos MS, Pacheco D, Ferreira FC, Sanjuan-Alberte P, et al. A 3D bioprinted spheroid-laden dECM-enriched osteosarcoma model for enhanced drug testing and therapeutic discovery. Adv Healthc Mater. 2026;e03633. https:\/\/doi.org\/10.1002\/adhm.202503633.","DOI":"10.1002\/adhm.202503633"},{"key":"951_CR95","doi-asserted-by":"publisher","first-page":"035001","DOI":"10.1088\/1758-5082\/6\/3\/035001","volume":"6","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Yao R, Ouyang L, Ding H, Zhang T, Zhang K, et al. Three-dimensional printing of Hela cells for cervical tumor model in vitro. Biofabrication. 2014;6:035001. https:\/\/doi.org\/10.1088\/1758-5082\/6\/3\/035001.","journal-title":"Biofabrication"},{"key":"951_CR96","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.colsurfb.2018.08.006","volume":"171","author":"X Wang","year":"2018","unstructured":"Wang X, Li X, Dai X, Zhang X, Zhang J, Xu T, et al. Bioprinting of glioma stem cells improves their endotheliogenic potential. Colloids Surf B Biointerfaces. 2018;171:629\u201337. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.08.006.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"951_CR97","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.biomaterials.2018.09.026","volume":"185","author":"X Ma","year":"2018","unstructured":"Ma X, Yu C, Wang P, Xu W, Wan X, Lai CSE, et al. Rapid 3D bioprinting of decellularized extracellular matrix with regionally varied mechanical properties and biomimetic microarchitecture. Biomaterials. 2018;185:310\u201321. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.09.026.","journal-title":"Biomaterials"},{"key":"951_CR98","doi-asserted-by":"publisher","first-page":"639572","DOI":"10.3389\/fimmu.2021.639572","volume":"12","author":"FV Sbrana","year":"2021","unstructured":"Sbrana FV, Pinos R, Barbaglio F, Ribezzi D, Scagnoli F, Scarf\u00f2 L, et al. 3D Bioprinting Allows the Establishment of Long-Term 3D Culture Model for Chronic Lymphocytic Leukemia Cells. Front Immunol. 2021;12:639572. https:\/\/doi.org\/10.3389\/fimmu.2021.639572.","journal-title":"Front Immunol"},{"key":"951_CR99","doi-asserted-by":"publisher","first-page":"101449","DOI":"10.1016\/j.mtbio.2025.101449","volume":"31","author":"X Mei","year":"2025","unstructured":"Mei X, Uribe Estrada MF, Rizwan M, Lukin I, Sanchez Gonzalez B, Marin Canchola JG, et al. A bioprinted animal patient-derived breast cancer model for anti-cancer drug screening. Mater Today Bio. 2025;31:101449. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101449.","journal-title":"Mater Today Bio"},{"key":"951_CR100","doi-asserted-by":"publisher","unstructured":"Svanstr\u00f6m A, Rosendahl J, Salerno S, Leiva MC, Gregersson P, Berglin M, et al. Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery. Biomed Mater Bristol Engl. 2021;16. https:\/\/doi.org\/10.1088\/1748-605X\/ac0451.","DOI":"10.1088\/1748-605X\/ac0451"},{"key":"951_CR101","doi-asserted-by":"publisher","first-page":"117793","DOI":"10.1016\/j.carbpol.2021.117793","volume":"260","author":"A Gospodinova","year":"2021","unstructured":"Gospodinova A, Nankov V, Tomov S, Redzheb M, Petrov PD. Extrusion bioprinting of hydroxyethylcellulose-based bioink for cervical tumor model. Carbohydr Polym. 2021;260:117793. https:\/\/doi.org\/10.1016\/j.carbpol.2021.117793.","journal-title":"Carbohydr Polym"},{"key":"951_CR102","doi-asserted-by":"publisher","first-page":"755563","DOI":"10.3389\/fbioe.2021.755563","volume":"9","author":"Y Sbirkov","year":"2021","unstructured":"Sbirkov Y, Molander D, Milet C, Bodurov I, Atanasov B, Penkov R, et al. A Colorectal Cancer 3D Bioprinting Workflow as a Platform for Disease Modeling and Chemotherapeutic Screening. Front Bioeng Biotechnol. 2021;9:755563. https:\/\/doi.org\/10.3389\/fbioe.2021.755563.","journal-title":"Front Bioeng Biotechnol"},{"key":"951_CR103","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1021\/acsbiomaterials.1c00812","volume":"7","author":"J Kort-Mascort","year":"2021","unstructured":"Kort-Mascort J, Bao G, Elkashty O, Flores-Torres S, Munguia-Lopez JG, Jiang T, et al. Decellularized Extracellular Matrix Composite Hydrogel Bioinks for the Development of 3D Bioprinted Head and Neck in Vitro Tumor Models. ACS Biomater Sci Eng Am Chem Soc. 2021;7:5288\u2013300. https:\/\/doi.org\/10.1021\/acsbiomaterials.1c00812.","journal-title":"ACS Biomater Sci Eng Am Chem Soc"},{"key":"951_CR104","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3389\/fonc.2020.00878","volume":"10","author":"L Sun","year":"2020","unstructured":"Sun L, Yang H, Wang Y, Zhang X, Jin B, Xie F, et al. Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research. Front Oncol. 2020;10:878. https:\/\/doi.org\/10.3389\/fonc.2020.00878.","journal-title":"Front Oncol"},{"key":"951_CR105","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/bioengineering10060667","volume":"10","author":"S Zou","year":"2023","unstructured":"Zou S, Ye J, Wei Y, Xu J. Characterization of 3D-Bioprinted In Vitro Lung Cancer Models Using RNA-Sequencing Techniques. Bioengineering. 2023;10:667. https:\/\/doi.org\/10.3390\/bioengineering10060667.","journal-title":"Bioengineering"},{"key":"951_CR106","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s13205-018-1519-1","volume":"8","author":"X Wang","year":"2018","unstructured":"Wang X, Zhang X, Dai X, Wang X, Li X, Diao J, et al. Tumor-like lung cancer model based on 3D bioprinting. 3 Biotech. 2018;8:501. https:\/\/doi.org\/10.1007\/s13205-018-1519-1.","journal-title":"3 Biotech"},{"key":"951_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076071","author":"Y Mei","year":"2023","unstructured":"Mei Y, Wu D, Berg J, Tolksdorf B, Roehrs V, Kurreck A, et al. Generation of a Perfusable 3D Lung Cancer Model by Digital Light Processing. Int J Mol Sci [Internet] publisher. 2023. https:\/\/doi.org\/10.3390\/ijms24076071. [cited 2026 Jan 27];24.","journal-title":"Int J Mol Sci [Internet] publisher"},{"key":"951_CR108","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell Elsevier. 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell Elsevier"},{"key":"951_CR109","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","volume":"125","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125:5591\u20136. https:\/\/doi.org\/10.1242\/jcs.116392.","journal-title":"J Cell Sci"},{"key":"951_CR110","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107753.","journal-title":"Pharmacol Ther"},{"key":"951_CR111","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer Nat Publishing Group. 2020;20:174\u201386. https:\/\/doi.org\/10.1038\/s41568-019-0238-1.","journal-title":"Nat Rev Cancer Nat Publishing Group"},{"key":"951_CR112","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","volume":"71","author":"B Dirat","year":"2011","unstructured":"Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, et al. Cancer-Associated Adipocytes Exhibit an Activated Phenotype and Contribute to Breast Cancer Invasion. Cancer Res. 2011;71:2455\u201365. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3323.","journal-title":"Cancer Res"},{"key":"951_CR113","doi-asserted-by":"publisher","first-page":"122992","DOI":"10.1016\/j.lfs.2024.122992","volume":"355","author":"S Moghassemi","year":"2024","unstructured":"Moghassemi S, Dadashzadeh A, Amorim CA. A novel bioprinted microtumour model for studying acute-leukemia-cell- contaminated in ovarian tissue. Life Sci. 2024;355:122992. https:\/\/doi.org\/10.1016\/j.lfs.2024.122992.","journal-title":"Life Sci"},{"key":"951_CR114","doi-asserted-by":"publisher","first-page":"e2100884","DOI":"10.1002\/adhm.202100884","volume":"11","author":"D Wu","year":"2022","unstructured":"Wu D, Wang Z, Li J, Song Y, Perez MEM, Wang Z, et al. A 3D-Bioprinted Multiple Myeloma Model. Adv Healthc Mater. 2022;11:e2100884. https:\/\/doi.org\/10.1002\/adhm.202100884.","journal-title":"Adv Healthc Mater"},{"key":"951_CR115","doi-asserted-by":"publisher","first-page":"e1806590","DOI":"10.1002\/adma.201806590","volume":"31","author":"MA Heinrich","year":"2019","unstructured":"Heinrich MA, Bansal R, Lammers T, Zhang YS, Michel Schiffelers R, Prakash J. 3D-Bioprinted Mini-Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics. Adv Mater Deerfield Beach Fla. 2019;31:e1806590. https:\/\/doi.org\/10.1002\/adma.201806590.","journal-title":"Adv Mater Deerfield Beach Fla"},{"key":"951_CR116","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s41422-020-0338-1","volume":"30","author":"M Tang","year":"2020","unstructured":"Tang M, Xie Q, Gimple RC, Zhong Z, Tam T, Tian J, et al. Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions. Cell Res. 2020;30:833\u201353. https:\/\/doi.org\/10.1038\/s41422-020-0338-1.","journal-title":"Cell Res"},{"key":"951_CR117","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/ijms23010122","volume":"23","author":"D Wu","year":"2022","unstructured":"Wu D, Berg J, Arlt B, R\u00f6hrs V, Al-Zeer MA, Deubzer HE, et al. Bioprinted Cancer Model of Neuroblastoma in a Renal Microenvironment as an Efficiently Applicable Drug Testing Platform. Int J Mol Sci Multidisciplinary Digit Publishing Inst. 2022;23:122. https:\/\/doi.org\/10.3390\/ijms23010122.","journal-title":"Int J Mol Sci Multidisciplinary Digit Publishing Inst"},{"key":"951_CR118","doi-asserted-by":"publisher","first-page":"1484738","DOI":"10.3389\/fbioe.2025.1484738","volume":"13","author":"F Maggiotto","year":"2025","unstructured":"Maggiotto F, Bova L, Micheli S, Pozzer C, Fusco P, Sgarbossa P, et al. 3D bioprinting for the production of a perfusable vascularized model of a cancer niche. Front Bioeng Biotechnol. 2025;13:1484738. https:\/\/doi.org\/10.3389\/fbioe.2025.1484738.","journal-title":"Front Bioeng Biotechnol"},{"key":"951_CR119","doi-asserted-by":"publisher","first-page":"689697","DOI":"10.3389\/fimmu.2021.689697","volume":"12","author":"L Grunewald","year":"2021","unstructured":"Grunewald L, Lam T, Andersch L, Klaus A, Schwiebert S, Winkler A, et al. A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy Optimization. Front Immunol. 2021;12:689697. https:\/\/doi.org\/10.3389\/fimmu.2021.689697.","journal-title":"Front Immunol"},{"key":"951_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1677361","author":"L Andersch","year":"2025","unstructured":"Andersch L, Grunewald L, Stecklum M, Klironomos F, Haase K, Hollek V, et al. Investigating genetic modifications to enhance L1CAM-CAR T cell migration in solid tumors in a 3D bioprinted neuroblastoma model. Front Immunol [Internet] Front. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1677361. [cited 2026 Jan 28];16.","journal-title":"Front Immunol [Internet] Front"},{"key":"951_CR121","doi-asserted-by":"publisher","first-page":"2303716","DOI":"10.1002\/adhm.202303716","volume":"13","author":"G Lee","year":"2024","unstructured":"Lee G, Kim SJ, Park J-K. Bioprinted Multi-Composition Array Mimicking Tumor Microenvironments to Evaluate Drug Efficacy with Multivariable Analysis. Adv Healthc Mater. 2024;13:2303716. https:\/\/doi.org\/10.1002\/adhm.202303716.","journal-title":"Adv Healthc Mater"},{"key":"951_CR122","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/gels6010010","volume":"6","author":"S Chaji","year":"2020","unstructured":"Chaji S, Al-Saleh J, Gomillion CT. Bioprinted Three-Dimensional Cell-Laden Hydrogels to Evaluate Adipocyte-Breast Cancer Cell Interactions. Gels Basel Switz. 2020;6:10. https:\/\/doi.org\/10.3390\/gels6010010.","journal-title":"Gels Basel Switz"},{"key":"951_CR123","doi-asserted-by":"publisher","first-page":"111152","DOI":"10.1016\/j.matdes.2022.111152","volume":"223","author":"X Wei","year":"2022","unstructured":"Wei X, Huang B, Chen K, Fan Z, Wang L, Xu M. Dot extrusion bioprinting of spatially controlled heterogenous tumor models. Mater Des. 2022;223:111152. https:\/\/doi.org\/10.1016\/j.matdes.2022.111152.","journal-title":"Mater Des"},{"key":"951_CR124","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.celrep.2018.12.090","volume":"26","author":"EM Langer","year":"2019","unstructured":"Langer EM, Allen-Petersen BL, King SM, Kendsersky ND, Turnidge MA, Kuziel GM, et al. Modeling Tumor Phenotypes In Vitro with Three-Dimensional Bioprinting. Cell Rep. 2019;26:608\u2013e6236. https:\/\/doi.org\/10.1016\/j.celrep.2018.12.090.","journal-title":"Cell Rep"},{"key":"951_CR125","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bioactmat.2024.08.037","volume":"42","author":"T Desigaux","year":"2024","unstructured":"Desigaux T, Comperat L, Dusserre N, Stachowicz M-L, Lea M, Dupuy J-W, et al. 3D bioprinted breast cancer model reveals stroma-mediated modulation of extracellular matrix and radiosensitivity. Bioact Mater. 2024;42:316\u201327. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.08.037.","journal-title":"Bioact Mater"},{"key":"951_CR126","doi-asserted-by":"publisher","first-page":"e2404642","DOI":"10.1002\/adhm.202404642","volume":"14","author":"Y Chen","year":"2025","unstructured":"Chen Y, Xue Y, Yan C, Jin J, Liu Y, Li J, et al. Bioprinted Fibroblast Mediated Heterogeneous Tumor Microenvironment for Studying Tumor-Stroma Interaction and Drug Screening. Adv Healthc Mater. 2025;14:e2404642. https:\/\/doi.org\/10.1002\/adhm.202404642.","journal-title":"Adv Healthc Mater"},{"key":"951_CR127","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1002\/adma.201501729","volume":"27","author":"JM Grolman","year":"2015","unstructured":"Grolman JM, Zhang D, Smith AM, Moore JS, Kilian KA. Rapid 3D Extrusion of Synthetic Tumor Microenvironments. Adv Mater Deerfield Beach Fla. 2015;27:5512\u20137. https:\/\/doi.org\/10.1002\/adma.201501729.","journal-title":"Adv Mater Deerfield Beach Fla"},{"key":"951_CR128","doi-asserted-by":"publisher","first-page":"30017","DOI":"10.1021\/acsami.6b10673","volume":"8","author":"X Zhou","year":"2016","unstructured":"Zhou X, Zhu W, Nowicki M, Miao S, Cui H, Holmes B, et al. 3D Bioprinting a Cell-Laden Bone Matrix for Breast Cancer Metastasis Study. ACS Appl Mater Interfaces. 2016;8:30017\u201326. https:\/\/doi.org\/10.1021\/acsami.6b10673.","journal-title":"ACS Appl Mater Interfaces"},{"key":"951_CR129","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.tibtech.2024.06.007","volume":"42","author":"T Yuan","year":"2024","unstructured":"Yuan T, Fu X, Hu R, Zheng X, Jiang D, Jing L, et al. Bioprinted, spatially defined breast tumor microenvironment models of intratumoral heterogeneity and drug resistance. Trends Biotechnol Elsevier. 2024;42:1523\u201350. https:\/\/doi.org\/10.1016\/j.tibtech.2024.06.007.","journal-title":"Trends Biotechnol Elsevier"},{"key":"951_CR130","doi-asserted-by":"publisher","first-page":"045022","DOI":"10.1088\/1748-605X\/acd830","volume":"18","author":"J Kort-Mascort","year":"2023","unstructured":"Kort-Mascort J, Shen ML, Martin E, Flores-Torres S, Pardo LA, Siegel PM, et al. Bioprinted cancer-stromal in-vitro models in a decellularized ECM-based bioink exhibit progressive remodeling and maturation. Biomed Mater IOP Publishing. 2023;18:045022. https:\/\/doi.org\/10.1088\/1748-605X\/acd830.","journal-title":"Biomed Mater IOP Publishing"},{"key":"951_CR131","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.actbio.2024.07.019","volume":"185","author":"X Wang","year":"2024","unstructured":"Wang X, Yang X, Liu Z, Shen Z, Li M, Cheng R, et al. 3D bioprinting of an in vitro hepatoma microenvironment model: Establishment, evaluation, and anticancer drug testing. Acta Biomater. 2024;185:173\u201389. https:\/\/doi.org\/10.1016\/j.actbio.2024.07.019.","journal-title":"Acta Biomater"},{"key":"951_CR132","doi-asserted-by":"publisher","first-page":"e1806899","DOI":"10.1002\/adma.201806899","volume":"31","author":"F Meng","year":"2019","unstructured":"Meng F, Meyer CM, Joung D, Vallera DA, McAlpine MC, Panoskaltsis-Mortari A. 3D Bioprinted In Vitro Metastatic Models via Reconstruction of Tumor Microenvironments. Adv Mater Deerfield Beach Fla. 2019;31:e1806899. https:\/\/doi.org\/10.1002\/adma.201806899.","journal-title":"Adv Mater Deerfield Beach Fla"},{"key":"951_CR133","doi-asserted-by":"publisher","first-page":"e00243","DOI":"10.1016\/j.bprint.2022.e00243","volume":"28","author":"P Das","year":"2022","unstructured":"Das P, Najafikhoshnoo S, Tavares-Negrete JA, Yi Q, Esfandyarpour R. An in-vivo-mimicking 3D lung cancer-on-a-chip model to study the effect of external stimulus on the progress and inhibition of cancer metastasis. Bioprinting. 2022;28:e00243. https:\/\/doi.org\/10.1016\/j.bprint.2022.e00243.","journal-title":"Bioprinting"},{"key":"951_CR134","doi-asserted-by":"publisher","first-page":"19914","DOI":"10.1038\/s41598-019-55034-9","volume":"9","author":"A Mondal","year":"2019","unstructured":"Mondal A, Gebeyehu A, Miranda M, Bahadur D, Patel N, Ramakrishnan S, et al. Characterization and printability of Sodium alginate -Gelatin hydrogel for bioprinting NSCLC co-culture. Sci Rep. 2019;9:19914. https:\/\/doi.org\/10.1038\/s41598-019-55034-9.","journal-title":"Sci Rep"},{"key":"951_CR135","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/diseases12090206","volume":"12","author":"C Godier","year":"2024","unstructured":"Godier C, Baka Z, Lamy L, Gribova V, Marchal P, Lavalle P, et al. A 3D Bio-Printed-Based Model for Pancreatic Ductal Adenocarcinoma. Diseases. Multidisciplinary Digit Publishing Inst. 2024;12:206. https:\/\/doi.org\/10.3390\/diseases12090206.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"951_CR136","doi-asserted-by":"publisher","unstructured":"Xu K, Huang Y, Wu M, Yin J, Wei P. 3D bioprinting of multi-cellular tumor microenvironment for prostate cancer metastasis. Biofabrication. 2023;15. https:\/\/doi.org\/10.1088\/1758-5090\/acd960.","DOI":"10.1088\/1758-5090\/acd960"},{"key":"951_CR137","doi-asserted-by":"crossref","unstructured":"Arava AC, Ameril C, Aggarwal A, Munirathinam G, Alam MF. Abstract 1232: a 3D bioprinted prostate cancer ex vivo model with nanoengineered hydrogel for potential drug screening. [cited 2026 Apr 15]; https:\/\/aacrjournals-org.docelec.univ-lyon1.fr\/cancerres\/article\/85\/8_Supplement_1\/1232\/755692\/Abstract-1232-A-3D-bioprinted-prostate-cancer-ex. Accessed 15 Apr 2026.","DOI":"10.1158\/1538-7445.AM2025-1232"},{"key":"951_CR138","doi-asserted-by":"publisher","first-page":"e2401136","DOI":"10.1002\/adhm.202401136","volume":"13","author":"P V\u00e1zquez-Aristizabal","year":"2024","unstructured":"V\u00e1zquez-Aristizabal P, Henriksen-Lacey M, Garc\u00eda-Astrain C, Jimenez de Aberasturi D, Langer J, Epelde C, et al. Biofabrication and Monitoring of a 3D Printed Skin Model for Melanoma. Adv Healthc Mater. 2024;13:e2401136. https:\/\/doi.org\/10.1002\/adhm.202401136.","journal-title":"Adv Healthc Mater"},{"key":"951_CR139","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11:5120. https:\/\/doi.org\/10.1038\/s41467-020-18794-x.","journal-title":"Nat Commun"},{"key":"951_CR140","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/cac2.12414","volume":"43","author":"JW Eun","year":"2023","unstructured":"Eun JW, Yoon JH, Ahn HR, Kim S, Kim YB, Lim SB, et al. Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib. Cancer Commun Lond Engl. 2023;43:455\u201379. https:\/\/doi.org\/10.1002\/cac2.12414.","journal-title":"Cancer Commun Lond Engl"},{"key":"951_CR141","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19:43. https:\/\/doi.org\/10.1186\/s12943-020-01168-8.","journal-title":"Mol Cancer"},{"key":"951_CR142","doi-asserted-by":"publisher","first-page":"100960","DOI":"10.1016\/j.drup.2023.100960","volume":"68","author":"R Qi","year":"2023","unstructured":"Qi R, Bai Y, Li K, Liu N, Xu Y, Dal E, et al. Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother. 2023;68:100960. https:\/\/doi.org\/10.1016\/j.drup.2023.100960.","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother"},{"key":"951_CR143","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398. https:\/\/doi.org\/10.1038\/nrc.2016.73.","journal-title":"Nat Rev Cancer"},{"key":"951_CR144","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3892\/mmr.2021.12506","volume":"24","author":"H Yao","year":"2021","unstructured":"Yao H, He S. Multi\u2013faceted role of cancer\u2013associated adipocytes in the tumor microenvironment (Review). Mol Med Rep. 2021;24:866. https:\/\/doi.org\/10.3892\/mmr.2021.12506.","journal-title":"Mol Med Rep"},{"key":"951_CR145","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13058-015-0569-0","volume":"17","author":"MN Duong","year":"2015","unstructured":"Duong MN, Cleret A, Matera E-L, Chettab K, Math\u00e9 D, Valsesia-Wittmann S, et al. Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity. Breast Cancer Res BCR. 2015;17:57. https:\/\/doi.org\/10.1186\/s13058-015-0569-0.","journal-title":"Breast Cancer Res BCR"},{"key":"951_CR146","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13058-018-1088-6","volume":"21","author":"C Lehu\u00e9d\u00e9","year":"2019","unstructured":"Lehu\u00e9d\u00e9 C, Li X, Dauvillier S, Vaysse C, Franchet C, Clement E, et al. Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP). Breast Cancer Res BCR. 2019;21:7. https:\/\/doi.org\/10.1186\/s13058-018-1088-6.","journal-title":"Breast Cancer Res BCR"},{"key":"951_CR147","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40360-020-00436-z","volume":"21","author":"A Geneste","year":"2020","unstructured":"Geneste A, Duong MN, Molina L, Conilh L, Beaumel S, Cleret A, et al. Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib. BMC Pharmacol Toxicol. 2020;21:61. https:\/\/doi.org\/10.1186\/s40360-020-00436-z.","journal-title":"BMC Pharmacol Toxicol"},{"key":"951_CR148","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1158\/0008-5472.CAN-23-0505","volume":"83","author":"C Bouche","year":"2023","unstructured":"Bouche C, Quail DF. Fueling the Tumor Microenvironment with Cancer-Associated Adipocytes. Cancer Res. 2023;83:1170\u20132. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0505.","journal-title":"Cancer Res"},{"key":"951_CR149","doi-asserted-by":"publisher","first-page":"e1900924","DOI":"10.1002\/adhm.201900924","volume":"9","author":"H Cui","year":"2020","unstructured":"Cui H, Esworthy T, Zhou X, Hann SY, Glazer RI, Li R, et al. Engineering a novel 3D printed vascularized tissue model for investigating breast cancer metastasis to bone. Adv Healthc Mater. 2020;9:e1900924. https:\/\/doi.org\/10.1002\/adhm.201900924.","journal-title":"Adv Healthc Mater"},{"key":"951_CR150","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/jcb.21187","volume":"101","author":"D Fukumura","year":"2007","unstructured":"Fukumura D, Jain RK. Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize. J Cell Biochem. 2007;101:937\u201349. https:\/\/doi.org\/10.1002\/jcb.21187.","journal-title":"J Cell Biochem"},{"key":"951_CR151","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1039\/C4BM00234B","volume":"3","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Yu Y, Akkouch A, Dababneh A, Dolati F, Ozbolat IT. In Vitro Study of Directly Bioprinted Perfusable Vasculature Conduits. Biomater Sci. 2015;3:134\u201343. https:\/\/doi.org\/10.1039\/C4BM00234B.","journal-title":"Biomater Sci"},{"key":"951_CR152","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.tibtech.2019.04.009","volume":"37","author":"J Parrish","year":"2019","unstructured":"Parrish J, Lim K, Zhang B, Radisic M, Woodfield TBF. New Frontiers for Biofabrication and Bioreactor Design in Microphysiological System Development. Trends Biotechnol. 2019;37:1327\u201343. https:\/\/doi.org\/10.1016\/j.tibtech.2019.04.009.","journal-title":"Trends Biotechnol"},{"key":"951_CR153","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10544-013-9812-6","volume":"16","author":"TQ Huang","year":"2014","unstructured":"Huang TQ, Qu X, Liu J, Chen S. 3D printing of biomimetic microstructures for cancer cell migration. Biomed Microdevices. 2014;16:127\u201332. https:\/\/doi.org\/10.1007\/s10544-013-9812-6.","journal-title":"Biomed Microdevices"},{"key":"951_CR154","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.tibtech.2021.08.007","volume":"40","author":"MV Monteiro","year":"2022","unstructured":"Monteiro MV, Zhang YS, Gaspar VM, Mano JF. 3D-bioprinted cancer-on-a-chip: level-up organotypic in vitro models. Trends Biotechnol. 2022;40:432\u201347. https:\/\/doi.org\/10.1016\/j.tibtech.2021.08.007.","journal-title":"Trends Biotechnol"},{"key":"951_CR155","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.drudis.2021.03.010","volume":"26","author":"AP Tiwari","year":"2021","unstructured":"Tiwari AP, Thorat ND, Pricl S, Patil RM, Rohiwal S, Townley H. Bioink: a 3D-bioprinting tool for anticancer drug discovery and cancer management. Drug Discov Today. 2021;26:1574\u201390. https:\/\/doi.org\/10.1016\/j.drudis.2021.03.010.","journal-title":"Drug Discov Today"},{"key":"951_CR156","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/cancers14010190","volume":"14","author":"MAG Barbosa","year":"2021","unstructured":"Barbosa MAG, Xavier CPR, Pereira RF, Petrikait\u0117 V, Vasconcelos MH. 3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs. Cancers. 2021;14:190. https:\/\/doi.org\/10.3390\/cancers14010190.","journal-title":"Cancers"},{"key":"951_CR157","doi-asserted-by":"publisher","first-page":"e2403114","DOI":"10.1002\/adhm.202403114","volume":"14","author":"A Azhakesan","year":"2025","unstructured":"Azhakesan A, Kern J, Mishra A, Selhuber-Unkel C, Affolter A, Gatenholm P, et al. 3D Bioprinted Head and Neck Squamous Cell Carcinoma (HNSCC) Model Using Tunicate Derived Nanocellulose (NC) Bioink. Adv Healthc Mater. 2025;14:e2403114. https:\/\/doi.org\/10.1002\/adhm.202403114.","journal-title":"Adv Healthc Mater"},{"key":"951_CR158","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fphar.2018.00006","volume":"9","author":"SA Langhans","year":"2018","unstructured":"Langhans SA. Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning. Front Pharmacol. 2018;9:6. https:\/\/doi.org\/10.3389\/fphar.2018.00006.","journal-title":"Front Pharmacol"},{"key":"951_CR159","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41467-020-16199-4","volume":"11","author":"O Saatci","year":"2020","unstructured":"Saatci O, Kaymak A, Raza U, Ersan PG, Akbulut O, Banister CE, et al. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nat Commun. 2020;11:2416. https:\/\/doi.org\/10.1038\/s41467-020-16199-4.","journal-title":"Nat Commun"},{"key":"951_CR160","doi-asserted-by":"publisher","first-page":"641980","DOI":"10.3389\/fonc.2021.641980","volume":"11","author":"M Verduin","year":"2021","unstructured":"Verduin M, Hoeben A, De Ruysscher D, Vooijs M. Patient-Derived Cancer Organoids as Predictors of Treatment Response. Front Oncol. 2021;11:641980. https:\/\/doi.org\/10.3389\/fonc.2021.641980.","journal-title":"Front Oncol"},{"key":"951_CR161","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.medj.2024.08.010","volume":"5","author":"L Tong","year":"2024","unstructured":"Tong L, Cui W, Zhang B, Fonseca P, Zhao Q, Zhang P, et al. Patient-derived organoids in precision cancer medicine. Med N Y N. 2024;5:1351\u201377. https:\/\/doi.org\/10.1016\/j.medj.2024.08.010.","journal-title":"Med N Y N"},{"key":"951_CR162","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","volume":"56","author":"L Thorel","year":"2024","unstructured":"Thorel L, Perr\u00e9ard M, Florent R, Divoux J, Coffy S, Vincent A, et al. Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology. Exp Mol Med Nat Publishing Group. 2024;56:1531\u201351. https:\/\/doi.org\/10.1038\/s12276-024-01272-5.","journal-title":"Exp Mol Med Nat Publishing Group"},{"key":"951_CR163","doi-asserted-by":"publisher","first-page":"767697","DOI":"10.3389\/fonc.2021.767697","volume":"11","author":"AR Templeton","year":"2021","unstructured":"Templeton AR, Jeffery PL, Thomas PB, Perera MPJ, Ng G, Calabrese AR, et al. Patient-Derived Explants as a Precision Medicine Patient-Proximal Testing Platform Informing Cancer Management. Front Oncol. 2021;11:767697. https:\/\/doi.org\/10.3389\/fonc.2021.767697.","journal-title":"Front Oncol"},{"key":"951_CR164","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12951-025-03934-6","volume":"24","author":"L Du","year":"2025","unstructured":"Du L, Zheng Z, Wang Y, Zhang K, Lu Y, Sun M, et al. Three-dimensional bioprinting of patient-derived Gastrointestinal stromal tumor: a novel platform for precision oncology and drug response profiling. J Nanobiotechnol. 2025;24:64. https:\/\/doi.org\/10.1186\/s12951-025-03934-6.","journal-title":"J Nanobiotechnol"},{"key":"951_CR165","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12943-025-02466-9","volume":"24","author":"L Du","year":"2025","unstructured":"Du L, Zheng Z, Zhang K, Sun H, Lu Y, Sun M, et al. Exploring personalized prediction of clinical chemotherapy efficacy and revealing tumor heterogeneity using patient-derived 3D bioprinting gastric cancer models. Mol Cancer. 2025;24:259. https:\/\/doi.org\/10.1186\/s12943-025-02466-9.","journal-title":"Mol Cancer"},{"key":"951_CR166","doi-asserted-by":"publisher","first-page":"102878","DOI":"10.1016\/j.mtbio.2026.102878","volume":"37","author":"B Liu","year":"2026","unstructured":"Liu B, Cheng H, Yu K, Xu W, Tian X, Xu Y, et al. Biomimetic 3D-Bioprinted organoids of thymic epithelial tumors for translational drug screening and biomarker identification. Mater Today Bio. 2026;37:102878. https:\/\/doi.org\/10.1016\/j.mtbio.2026.102878.","journal-title":"Mater Today Bio"},{"key":"951_CR167","doi-asserted-by":"publisher","first-page":"eabi9119","DOI":"10.1126\/sciadv.abi9119","volume":"7","author":"L Neufeld","year":"2021","unstructured":"Neufeld L, Yeini E, Reisman N, Shtilerman Y, Ben-Shushan D, Pozzi S, et al. Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment. Sci Adv. 2021;7:eabi9119. https:\/\/doi.org\/10.1126\/sciadv.abi9119.","journal-title":"Sci Adv"},{"key":"951_CR168","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41551-019-0363-x","volume":"3","author":"H-G Yi","year":"2019","unstructured":"Yi H-G, Jeong YH, Kim Y, Choi Y-J, Moon HE, Park SH, et al. A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy. Nat Biomed Eng. 2019;3:509\u201319. https:\/\/doi.org\/10.1038\/s41551-019-0363-x.","journal-title":"Nat Biomed Eng"},{"key":"951_CR169","doi-asserted-by":"publisher","first-page":"2304460","DOI":"10.1002\/advs.202304460","volume":"11","author":"H Sun","year":"2024","unstructured":"Sun H, Sun L, Ke X, Liu L, Li C, Jin B, et al. Prediction of Clinical Precision Chemotherapy by Patient-Derived 3D Bioprinting Models of Colorectal Cancer and Its Liver Metastases. Adv Sci. 2024;11:2304460. https:\/\/doi.org\/10.1002\/advs.202304460.","journal-title":"Adv Sci"},{"key":"951_CR170","doi-asserted-by":"publisher","first-page":"e2102784","DOI":"10.1002\/adhm.202102784","volume":"11","author":"H Chen","year":"2022","unstructured":"Chen H, Wu Z, Gong Z, Xia Y, Li J, Du L, et al. Acoustic Bioprinting of Patient-Derived Organoids for Predicting Cancer Therapy Responses. Adv Healthc Mater. 2022;11:e2102784. https:\/\/doi.org\/10.1002\/adhm.202102784.","journal-title":"Adv Healthc Mater"},{"key":"951_CR171","doi-asserted-by":"publisher","first-page":"120416","DOI":"10.1016\/j.biomaterials.2020.120416","volume":"265","author":"F Xie","year":"2021","unstructured":"Xie F, Sun L, Pang Y, Xu G, Jin B, Xu H, et al. Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine. Biomaterials. 2021;265:120416. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120416.","journal-title":"Biomaterials"},{"key":"951_CR172","doi-asserted-by":"publisher","first-page":"111914","DOI":"10.1016\/j.msec.2021.111914","volume":"122","author":"A Herreros-Pomares","year":"2021","unstructured":"Herreros-Pomares A, Zhou X, Calabuig-Fari\u00f1as S, Lee S-J, Torres S, Esworthy T, et al. 3D printing novel in vitro cancer cell culture model systems for lung cancer stem cell study. Mater Sci Eng C. 2021;122:111914. https:\/\/doi.org\/10.1016\/j.msec.2021.111914.","journal-title":"Mater Sci Eng C"},{"key":"951_CR173","doi-asserted-by":"publisher","first-page":"101823","DOI":"10.1016\/j.mtbio.2025.101823","volume":"32","author":"S Xu","year":"2025","unstructured":"Xu S, Sun X, Gu Y, Liu T, Liu S, Weng Y, et al. ECM characterization and 3D bioprinted models of NSCLC for investigating stiffness-dependent tumor behavior and drug response. Mater Today Bio. 2025;32:101823. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101823.","journal-title":"Mater Today Bio"},{"key":"951_CR174","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jare.2024.09.011","volume":"74","author":"H Sun","year":"2025","unstructured":"Sun H, Wang Y, Sun M, Ke X, Li C, Jin B, et al. Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer. J Adv Res. 2025;74:165\u201374. https:\/\/doi.org\/10.1016\/j.jare.2024.09.011.","journal-title":"J Adv Res"},{"key":"951_CR175","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1158\/1538-7445.AM2026-4872","volume":"86","author":"A Cadiou","year":"2026","unstructured":"Cadiou A, Thiollier-Schmitt C, Devret G, Guelminger R, Fenouil T, Perrin C, et al. Abstract 4872: 3D bioprinting of fresh NSCLC: The Lung3Dprint proof of concept study. Cancer Res. 2026;86:4872. https:\/\/doi.org\/10.1158\/1538-7445.AM2026-4872.","journal-title":"Cancer Res"},{"key":"951_CR176","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/cells14151153","volume":"14","author":"A Yu","year":"2025","unstructured":"Yu A, Ma C, Hu M. Rejuvenated Autologous Adult Stem Cells: Emerging Front Runners in the Fight Against Aging and Associated Diseases. Cells. 2025;14:1153. https:\/\/doi.org\/10.3390\/cells14151153.","journal-title":"Cells"},{"key":"951_CR177","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1158\/2326-6066.CIR-21-0802","volume":"10","author":"M Denis","year":"2022","unstructured":"Denis M, Grasselly C, Choffour P-A, Wierinckx A, Math\u00e9 D, Chettab K, et al. In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti-PD-1\/PD-L1 Therapies. Cancer Immunol Res. 2022;10:1013\u201327. https:\/\/doi.org\/10.1158\/2326-6066.CIR-21-0802.","journal-title":"Cancer Immunol Res"},{"key":"951_CR178","doi-asserted-by":"publisher","first-page":"e00617","DOI":"10.1002\/prp2.617","volume":"8","author":"J Sauveur","year":"2020","unstructured":"Sauveur J, Conilh L, Beaumel S, Chettab K, Jordheim L, Matera E, et al. Characterization of T-DM1\u2010resistant breast cancer cells. Pharmacol Res Perspect. 2020;8:e00617. https:\/\/doi.org\/10.1002\/prp2.617.","journal-title":"Pharmacol Res Perspect"},{"key":"951_CR179","doi-asserted-by":"publisher","first-page":"12906","DOI":"10.3390\/ijms241612906","volume":"24","author":"I Car","year":"2023","unstructured":"Car I, Dittmann A, Vasieva O, Bo\u010dkor L, Grb\u010di\u0107 P, Pite\u0161a N, et al. Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon Cancer and Melanoma Cells In Vitro. Int J Mol Sci. 2023;24:12906. https:\/\/doi.org\/10.3390\/ijms241612906.","journal-title":"Int J Mol Sci"},{"key":"951_CR180","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1021\/acs.nanolett.5b01688","volume":"15","author":"MK Gupta","year":"2015","unstructured":"Gupta MK, Meng F, Johnson BN, Kong YL, Tian L, Yeh Y-W, et al. 3D Printed Programmable Release Capsules. Nano Lett. 2015;15:5321\u20139. https:\/\/doi.org\/10.1021\/acs.nanolett.5b01688.","journal-title":"Nano Lett"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-00951-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00951-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00951-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:49:49Z","timestamp":1788324589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-00951-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":180,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["951"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-00951-x","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A. Cadiou is an employee of Antineo. C. Dumontet is a shareholder of Antineo.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"105"}}